Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Telemedicine-supported Management of Acute Ischemic Stroke in the Basic-level Hospitals

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Telemedicine-supported stroke care can provide standardized guidance to hospitals and regions with limited medical resources, thereby improving treatment outcomes for stroke patients in these areas. While this approach has been widely adopted in many developed countries, its efficacy in guiding basic-level hospitals to manage acute ischemic stroke requires further investigation through large-scale, high-quality studies. This study focused on patients with acute ischemic stroke who sought treatment at basic-level hospitals, aiming to investigate the efficacy and safety of treating acute ischemic stroke with telemedicine-supported management. Hospitals assigned to the experimental group received remote consultation guidance, quality control and professional training from expert teams at leading stroke centers, China National Center for Neurological Disorders. Hospitals in the control group did not receive telemedicine-supported management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Hospital Inclusion Criteria:

‣ Basic-level hospitals in China (Definition: Hospitals classified as secondary-level (Grade II) or below under China's Hospital Grading Management Standards, or hospitals located in counties/county-level cities).

⁃ Equipped with an emergency department and neurology ward capable of admitting stroke patients.

⁃ Equipped with CT and/or MRI capable of diagnosing AIS.

⁃ Equipped with intravenous thrombolytic drugs for acute ischemic stroke.

• Patient Inclusion Criteria:

‣ Age ≥ 18 years.

⁃ Diagnosed with acute ischemic stroke.

⁃ CT/MRI confirms absence of intracerebral hemorrhage.

⁃ Onset of stroke symptoms ≤ 4.5 hours.

⁃ pre-stroke mRS score ≤1.

⁃ Informed consent obtained from patient or their legal representative.

Locations
Other Locations
China
Xuanwu Hospital
RECRUITING
Beijing
Contact Information
Primary
Xunming Ji
jixm@ccmu.edu.cn
01083198962
Backup
Chuanjie Wu
wuchuanjie@ccmu.edu.cn
01083199439
Time Frame
Start Date: 2026-02-02
Estimated Completion Date: 2027-12
Participants
Target number of participants: 2400
Treatments
Experimental: Telemedicine-Supported Group
Receive remote guidance from expert stroke centers for treatment of patients with intravenous thrombolysis, along with quality control for standardized workflow support, and professional training.
No_intervention: Standard Treatment Group without Telemedicine-Supported Management
Control-group patients will receive routine stroke care at their primary care hospitals, with no remote consultation, study-related quality control, or extra training. Care will follow the hospitals' usual protocols, including emergency assessment, neurological evaluation, imaging, and intravenous thrombolysis. Hospitals may continue their regular stroke-related training during the study to reflect real-world practice.
Related Therapeutic Areas
Sponsors
Leads: Capital Medical University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials